Effect of VEGF on neural differentiation of human embryonic stem cells in vitro

Abstract

The effects of vascular endothelial growth factor (VEGF) on neural differentiation of human embryonic stem cells (hESCs) in vitro and the possible mechanism were observed. The hESCs lines, TJMU1 and TJMU2, were established and stored by our laboratory. hESCs differentiated into neuronal cells through embryonic body formation. In this induction process, hESCs were divided into three groups: group A, routine induction; group B, routine induction+10 ng/mL VEGF; group C, routine induction+10 ng/mL VEGF+10 ng/mL VEGFR2/Fc. OCT4, Nestin and GFAP in each group were detected by RT-PCR, and the cells expressing Nestin and GFAP were counted by immunofluorescence. The percentage of Nestin positive cells in group B was significantly higher than in groups A and C, while the percentage of GFAP positive cells in group B was significantly lower than in groups A and C (P<0.01). There was no significant difference between groups A and C (P>0.05). It was concluded that VEGF, via VEGFR2, stimulated the neural differentiation of hESCs in vitro.

Keywords

human embryonic stem cell / differentiation / vascular endothelial growth factor / vascular endothelial growth factor receptor 2

References

[1] CarmelietP.. Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet, 2003, 4(9): 710-720

[2] NamiecińskaM., MarciniakK., NowakJ.Z.. VEGF as an angiogenic, neurotrophic, and neuroprotective factor. Postepy Hig Med Dosw (Online), 2005, 59: 573-583

[3] AndersonL., CaldwellM.A.. Human neural progenitor cell transplants into the subthalamic nucleus lead to functional recovery in a rat model of Parkinson’s disease. Neurobiol Dis, 2007, 27(2): 133-140

[4] LambrechtsD., CarmelietP.. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochim Biophys Acta, 2006, 1762(11–12): 1109-1121

[5] ZacharyI.. Neuroprotective role of vascular endothelial growth factor: signaling mechanisms, biological function, and therapeutic potential. Neurosignals, 2005, 14(5): 207-221

[6] BrusselmansK., BonoF., CollenD., et al.. A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia. J Biol Chem, 2005, 280(5): 3493-3499

[7] LeeH.J., KimK.S., ParkI.H., et al.. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS ONE, 2007, 2(1): e156

[8] ChenH., QianK., ZhangS.M., et al.. The derivation of two additional human embryonic stem cell lines from day 3 embryos with low morphological scores. Hum Reprod, 2005, 20(8): 2201-2206

[9] ZhangS.C., WernigM., DuncanI.D., et al.. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol, 2001, 19(12): 1129-1133

[10] CaiC.Y., GrabelL.. Directing the differentiation of embryonic stem cells to neural stem cells. Dev Dyna, 2007, 236(12): 3255-3266

[11] Ben-HurT., IdelsonM., KhanerH., et al.. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells, 2004, 22(7): 1246-1255

[12] ZengX., CaiJ., ChenJ., et al.. Dopaminergic differentiation of human embryonic stem cells. Stem Cells, 2004, 22(6): 925-940

[13] ShinS., MitalipovaM., NoggleS., et al.. Long term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells, 2006, 24(1): 125-138

[14] SchulzT.C., NoggleS.A., PalmariniG.M., et al.. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells, 2004, 22(7): 1218-1238

[15] MengH., ZhangZ., ZhangR., et al.. Biphasic effects of exogenous VEGF on VEGF expression of adult neural progenitors. Neurosci Lett, 2006, 393(2–3): 97-101

[16] ManiN., KhaibullinaA., KrumJ.M., et al.. Astrocyte growth effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical explants: receptor mediation and signal transduction pathways. Exp Neurol, 2005, 192(2): 394-406

[17] SunY., JinK., ChildsJ.T., et al.. Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. Dev Biol, 2006, 289(2): 329-335

[18] MaurerM.H., TrippsW.K., FeldmannR.E.Jr, et al.. Expression of vascular endothelial growth factor and its receptors in rat neural stem cells. Neurosci Lett, 2003, 344(3): 165-168

[19] GalliR., PaganoS.F., GrittiA., et al.. Regulation of neuronal differentiation in human CNS stem cell progeny by leukemia inhibitory factor. Dev Neurosci, 2000, 22(1–2): 86-95

[20] KimB.K., KimS.E., ShimJ.H., et al.. Neurogenic effect of vascular endothelial growth factor during germ layer formation of human embryonic stem cells. FEBS Lett, 2006, 580(25): 5869-5874

[21] WadaT., HaighJ.J., EmaM., et al.. Vascular endothelial growth factor directly inhibits primitive neural stem cell survival but promotes definitive neural stem cell survival. J Nuerosci, 2006, 26(25): 6803-6812

[22] BaiY., CuiM., MengZ., et al.. Ectopic expression of angiopoietin-1 promotes neuronal differentiation in neural progenitor cells through the Akt pathway. Biochem Biophys Res Commun, 2009, 378(2): 296-301

[23] JungK.H., ChuK., LeeS.T., et al.. Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation. Brain Res, 2006, 1073–1074: 190-201

[24] WangL., ChoppM., GreggS.R., et al.. Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab, 2008, 28(7): 1361-1368

[25] MilosevicJ., MaiselM., WegnerF., et al.. Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling. J Neurosci, 2007, 27(2): 412-421